Oral microbiota and vitamin D impact on oropharyngeal squamous cell carcinogenesis: a narrative literature review

References

• Ahn J, Segers S, Hayes RB. 2012. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 33(5):1055–1058.
   PubMed Web of Science ®Google Scholar
• Akutsu T, Kitamura H, Himeiwa S, Kitada S, Akasu T, Urashima M. 2020. Vitamin D and cancer survival: does vitamin D supplementation improve the survival of patients with cancer? Curr Oncol Rep. 22(6):62.
   PubMed Web of Science ®Google Scholar
• Al-Hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T, Idris AM, Johnson NW. 2017. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep. 7(1):1834.
   PubMed Web of Science ®Google Scholar
• Amin M.B., Edge S.B., Greene F.L., Byrd D.R., Brookland R.K., Washington M.K., Gershenwald J.E., Compton C.C., Hess K.R., Sullivan D.C., et al. eds. 2017. AJCC cancer staging manual. Cham: Springer International Publishing.
   Google Scholar
• Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR. 2006. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol. 57(2):234–240.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Tian T, Wei Z, Peck KN, Shih N, Chalian AA, O'Malley BW, Weinstein GS, Feldman MD, Alwine J, et al. 2017. Microbial signatures associated with oropharyngeal and oral squamous cell carcinomas. Sci Rep. 7(1):4036.
   PubMed Web of Science ®Google Scholar
• Bars PL, Matamoros S, Montassier E, Vacon FL, Potel G, Soueidan A, Jordana F, La Cochetière MF. d. 2017. The oral cavity microbiota: between health, oral disease, and cancers of the aerodigestive tract. Can J Microbiol. 63(6):475–492.
   PubMed Web of Science ®Google Scholar
• Bashir M, Prietl B, Tauschmann M, Mautner SI, Kump PK, Treiber G, Wurm P, Gorkiewicz G, Högenauer C, Pieber TR. 2016. Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr. 55(4):1479–1489.
   PubMed Web of Science ®Google Scholar
• Bertolini M, Dongari-Bagtzoglou A. 2019. The relationship of Candida albicans with the oral bacterial microbiome in health and disease. Adv Exp Med Biol. 1197:69–78.
   PubMed Web of Science ®Google Scholar
• Bochen F, Balensiefer B, Körner S, Bittenbring JT, Neumann F, Koch A, Bumm K, Marx A, Wemmert S, Papaspyrou G, et al. 2018. Vitamin D deficiency in head and neck cancer patients: prevalence, prognostic value and impact on immune function. Oncoimmunology. 7(9):e1476817.
   PubMed Web of Science ®Google Scholar
• Börnigen D, Ren B, Pickard R, Li J, Ozer E, Hartmann EM, Xiao W, Tickle T, Rider J, Gevers D, et al. 2017. Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer. Sci Rep. 7(1):17686.
   PubMed Web of Science ®Google Scholar
• Bouzid D, Merzouki S, Bachiri M, Ailane SE, Zerroug MM. 2017. Vitamin D 3 a new drug against Candida albicans. J Mycol Med. 27(1):79–82.
   PubMed Web of Science ®Google Scholar
• Broccolo F, Ciccarese G, Rossi A, Anselmi L, Drago F, Toniolo A. 2018. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in keratinizing versus non-keratinizing squamous cell carcinoma of the oropharynx. Infect Agent Cancer. 13(1):32.
   PubMedGoogle Scholar
• Bronzato JD, Bomfim RA, Edwards DH, Crouch D, Hector MP, Gomes BPF. 2020. Detection of Fusobacterium in oral and head and neck cancer samples: a systematic review and meta-analysis. Arch Oral Biol. 112:104669.
   PubMed Web of Science ®Google Scholar
• Carlberg C, Muñoz A. 2020. An update on vitamin D signaling and cancer. Semin Cancer Biol. S1044-579X(20):30114–30110.
   Google Scholar
• Carlberg C. 2017. Molecular endocrinology of vitamin D on the epigenome level. Mol Cell Endocrinol. 453:14–21.
   PubMed Web of Science ®Google Scholar
• Chang C, Geng F, Shi X, Li Y, Zhang X, Zhao X, Pan Y. 2019. The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma. Appl Microbiol Biotechnol. 103(3):1393–1404.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay I, Verma M, Panda M. 2019. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol Cancer Res Treat. 18:1533033819867354.
   Web of Science ®Google Scholar
• Cho BH, Jung YH, Kim DJ, Woo BH, Jung JE, Lee JH, Choi YW, Park HR. 2018. Acetylshikonin suppresses invasion of Porphyromonas gingivalis‑infected YD10B oral cancer cells by modulating the interleukin-8/matrix metalloproteinase axis . Mol Med Rep. 17(2):2327–2334.
   PubMed Web of Science ®Google Scholar
• Cho T, Nagao JI, Imayoshi R, Tanaka Y. 2014. Importance of diversity in the oral microbiota including Candida species revealed by high-throughput technologies. Int J Dent. 2014:454391 .
   PubMedGoogle Scholar
• Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. 2016. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 96(1):365–408.
   PubMed Web of Science ®Google Scholar
• Chuang CY, Sung WW, Wang L, Lin WL, Yeh KT, Su MC, Hsin CH, Lee SY, Wu BC, Cheng YW, et al. 2012. Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas. PLoS One. 7(10):e47541.
   PubMed Web of Science ®Google Scholar
• Chung M, York BR, Michaud DS. 2019. Oral health and cancer. Curr Oral Health Rep. 6(2):130–137.
   PubMedGoogle Scholar
• Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S, Moustafa AEA. 2018. Epstein-Barr virus and human papillomaviruses interactions and their roles in the initiation of epithelial-mesenchymal transition and cancer progression. Front Oncol. 8:111.
   PubMed Web of Science ®Google Scholar
• Deng Z, Uehara T, Maeda H, Hasegawa M, Matayoshi S, Kiyuna A, Agena S, Pan X, Zhang C, Yamashita Y, et al. 2014. Epstein-Barr Virus and human papillomavirus infections and genotype distribution in head and neck cancers. PLoS One. 9(11):e113702.
   PubMed Web of Science ®Google Scholar
• Dong S, Singh TP, Wei X, Yao H, Wang H. 2018. Protective effect of 1,25-dihydroxy vitamin D3 on pepsin-trypsin-resistant gliadin-induced tight junction injuries. Dig Dis Sci. 63(1):92–104.
   PubMed Web of Science ®Google Scholar
• Dudding T, Johansson M, Thomas SJ, Brennan P, Martin RM, Timpson NJ. 2018. Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization. Int J Cancer. 143(5):1029–1036.
   PubMed Web of Science ®Google Scholar
• Enepekides DJ, Black MJ, White JH. 1999. The independent and combined effects of RAR-, RXR-, and VDR-selective ligands on the growth of squamous cell carcinoma in vitro. J Otolaryngol. 28(2):83–89.
   PubMedGoogle Scholar
• Fakhoury HMA, Kvietys PR, AlKattan W, Anouti FA, Elahi MA, Karras SN, Grant WB. 2020. Vitamin D and intestinal homeostasis: barrier, microbiota, and immune modulation. J Steroid Biochem Mol Biol. 200:105663.
   PubMed Web of Science ®Google Scholar
• Fan X, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Freedman ND, Alekseyenko AV, Wu J, Yang L, Pei Z, et al. 2018. Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome. 6(1):59.
   PubMedGoogle Scholar
• Fanidi A, Muller DC, Midttun Ø, Ueland PM, Vollset SE, Relton C, Vineis P, Weiderpass E, Skeie G, Brustad M, et al. 2016. Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort. Sci Rep. 6(1):36017.
   PubMedGoogle Scholar
• Fathi N, Ahmadian E, Shahi S, Roshangar L, Khan H, Kouhsoltani M, Maleki Dizaj S, Sharifi S. 2019. Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed Pharmacother. 109:391–401.
   PubMed Web of Science ®Google Scholar
• Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. 2014. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 14(5):342–357.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• Filippis AD, Fiorentino M, Guida L, Annunziata M, Nastri L, Rizzo A. 2017. Vitamin D reduces the inflammatory response by Porphyromonas gingivalis infection by modulating human β-defensin-3 in human gingival epithelium and periodontal ligament cells. Int Immunopharmacol. 47:106–117.
   PubMed Web of Science ®Google Scholar
• Gallimidi AB, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, Nussbaum G, Elkin M. 2015. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 6(26):22613–22623.
   PubMedGoogle Scholar
• Ganly I, Yang L, Giese RA, Hao Y, Nossa CW, Morris LGT, Rosenthal M, Migliacci J, Kelly D, Tseng W, et al. 2019. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. Int J Cancer. 145(3):775–784 .
   PubMed Web of Science ®Google Scholar
• Gedlicka C, Hager G, Weissenbock M, Gedlicka W, Knerer B, Kornfehl J, Formanek M. 2006. 1,25[OH]2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck. J Oral Pathol Med. 35(8):472–478.
   PubMed Web of Science ®Google Scholar
• Geng F, Zhang Y, Lu Z, Zhang S, Pan Y. 2020. Fusobacterium nucleatum caused DNA damage and promoted cell proliferation by the Ku70/p53 pathway in oral cancer cells. DNA Cell Biol. 39(1):144–151.
   PubMed Web of Science ®Google Scholar
• Guerrero-Preston R, Godoy-Vitorino F, Jedlicka A, Rodríguez-Hilario A, González H, Bondy J, Lawson F, Folawiyo O, Michailidi C, Dziedzic A, et al. 2016. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment. Oncotarget. 7(32):51320–51334.
   PubMedGoogle Scholar
• Guerrero-Preston R, White JR, Godoy-Vitorino F, Rodríguez-Hilario A, Navarro K, González H, Michailidi C, Jedlicka A, Canapp S, Bondy J, et al. 2017. High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation. Oncotarget. 8(67):110931–110948.
   PubMedGoogle Scholar
• Guidry J, Birdwell C, Scott R. 2018. Epstein-Barr virus in the pathogenesis of oral cancers. Oral Dis. 24(4):497–508.
   PubMed Web of Science ®Google Scholar
• Guo L, Chen W, Zhu H, Chen Y, Wan X, Yang N, Xu S, Yu C, Chen L. 2014. Helicobacter pylori induces increased expression of the vitamin D receptor in immune responses. Helicobacter. 19(1):37–47.
   PubMed Web of Science ®Google Scholar
• Ha NH, Woo BH, Kim DJ, Ha ES, Choi JI, Kim SJ, Park BS, Lee JH, Park HR. 2015. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties. Tumour Biol. 36(12):9947–9960.
   PubMedGoogle Scholar
• Haussler MR, Jurutka PW, Mizwicki M, Norman AW. 2011. Vitamin D receptor (VDR)-mediated actions of 1α,25[OH]2vitamin D3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 25(4):543–559.
   PubMed Web of Science ®Google Scholar
• Hii C, Ferrante A. 2016. The non-genomic actions of vitamin D. Nutrients. 8(3):135.
   PubMed Web of Science ®Google Scholar
• Hooper SJ, Crean SJ, Lewis MAO, Spratt DA, Wade WG, Wilson MJ. 2006. Viable bacteria present within oral squamous cell carcinoma tissue. J Clin Microbiol. 44(5):1719–1725.
   PubMed Web of Science ®Google Scholar
• Hormia M, Willberg J, Ruokonen H, Syrjänen S. 2005. Marginal periodontium as a potential reservoir of human papillomavirus in oral mucosa. J Periodontol. 76(3):358–363.
   PubMed Web of Science ®Google Scholar
• Jethwa AR, Khariwala SS. 2017. Tobacco-related carcinogenesis in head and neck cancer. Cancer Metastasis Rev. 36(3):411–423.
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Prakash S. 2013. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial. J Clin Endocrinol Metab. 98(7):2944–2951.
   PubMed Web of Science ®Google Scholar
• Kabat AM, Srinivasan N, Maloy KJ. 2014. Modulation of immune development and function by intestinal microbiota. Trends Immunol. 35(11):507–517.
   PubMed Web of Science ®Google Scholar
• Kang W, Jia Z, Tang D, Zhang Z, Gao H, He K, Feng Q. 2019. Fusobacterium nucleatum facilitates apoptosis, ROS generation, and inflammatory cytokine production by activating AKT/MAPK and NF- κ B signaling pathways in human gingival fibroblasts. Oxid Med Cell Longev. 2019:1681972–1681922.
   PubMed Web of Science ®Google Scholar
• Kang W, Sun T, Tang D, Zhou J, Feng Q. 2019. Time-course transcriptome analysis of gingiva-derived mesenchymal stem cells reveals that fusobacterium nucleatum triggers oncogene expression in the process of cell differentiation. Front Cell Dev Biol. 7:359.
   PubMed Web of Science ®Google Scholar
• Kim JH, Yamaori S, Tanabe T, Johnson CH, Krausz KW, Kato S, Gonzalez FJ. 2013. Implication of intestinal VDR deficiency in inflammatory bowel disease. Biochim Biophys Acta. 1830(1):2118–2128.
   PubMed Web of Science ®Google Scholar
• Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. 2020. Free fatty acid receptors in health and disease. Physiol Rev. 100(1):171–210.
   PubMed Web of Science ®Google Scholar
• Kingsley K, Bergman C, Keiserman M, Mobley C. 2013. Oral cancer risk and vitamin D status, intake and supplementation: a review. OA Cancer. 1(1):6.
   Google Scholar
• Klimesova K, Jiraskova Zakostelska Z, Tlaskalova-Hogenova H. 2018. Oral bacterial and fungal microbiome impacts colorectal carcinogenesis. Front Microbiol. 9:774.
   PubMed Web of Science ®Google Scholar
• Koneva LA, Zhang Y, Virani S, Hall PB, McHugh JB, Chepeha DB, Wolf GT, Carey TE, Rozek LS, Sartor MA. 2018. HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers. Mol Cancer Res. 16(1):90–102.
   PubMed Web of Science ®Google Scholar
• Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, Picu A, Petcu L, Chifiriuc MC. 2018. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol. 9:1830.
   PubMed Web of Science ®Google Scholar
• Lechien JR, Descamps G, Seminerio I, Furgiuele S, Dequanter D, Mouawad F, Badoual C, Journe F, Saussez S. 2020. HPV involvement in the tumor microenvironment and immune treatment in head and neck squamous cell carcinomas. Cancers (Basel). 12(5):1060.
   Web of Science ®Google Scholar
• Lim Y, Fukuma N, Totsika M, Kenny L, Morrison M, Punyadeera C. 2018. The performance of an oral microbiome biomarker panel in predicting oral cavity and oropharyngeal cancers. Front Cell Infect Microbiol. 8:267.
   PubMed Web of Science ®Google Scholar
• Liu G, Zheng J, Zhuang L, Lv Y, Zhu G, Pi L, Wang J, Chen C, Li Z, Liu J, et al. 2018. A prognostic 5-lncRNA expression signature for head and neck squamous cell carcinoma. Sci Rep. 8(1):15250.
   PubMed Web of Science ®Google Scholar
• Maalmi H, Ordóñez-Mena JM, Schöttker B, Brenner H. 2014. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer. 50(8):1510–1521.
   PubMed Web of Science ®Google Scholar
• Maasland DHE, Brandt PA, van den KB, Goldbohm RA, Schouten LJ. 2014. Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results from the Netherlands Cohort Study. BMC Cancer. 14(1):187.
   PubMedGoogle Scholar
• Mäkinen A, Nawaz A, Mäkitie A, Meurman JH. 2018. Role of non-Albicans Candida and Candida albicans in oral squamous cell cancer patients. J Oral Maxillofac Surg. 76(12):2564–2571.
   PubMed Web of Science ®Google Scholar
• Malaguarnera L. 2020. Vitamin D and microbiota: two sides of the same coin in the immunomodulatory aspects. Int Immunopharmacol. 79:106112.
   PubMed Web of Science ®Google Scholar
• Małodobra-Mazur M, Paduch A, Lebioda A, Konopacka M, Rogoliński J, Szymczyk C, Wierzgoń J, Maciejewski A, Chmielik E, Jonkisz A, et al. 2012. VDR gene single nucleotide polymorphisms and their association with risk of oral cavity carcinoma. Acta Biochim Pol. 59(4):627–630.
   PubMed Web of Science ®Google Scholar
• Martinez I, Wang J, Hobson KF, Ferris RL, Khan SA. 2007. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer. 43(2):415–432.
   PubMed Web of Science ®Google Scholar
• Meyer JE, Harder J, Görögh T, Weise JB, Schubert S, Janssen D, Maune S. 2004. Human beta-defensin-2 in oral cancer with opportunistic Candida infection. Anticancer Res. 24(2B):1025–1030.
   PubMed Web of Science ®Google Scholar
• Molinari C, Rizzi M, Squarzanti DF, Pittarella P, Vacca G, Renò F. 2013. 1α,25-Dihydroxycholecalciferol (Vitamin D3) induces NO-dependent endothelial cell proliferation and migration in a three-dimensional matrix. Cell Physiol Biochem. 31(6):815–822.
   PubMedGoogle Scholar
• Morbini P, Benazzo M. 2016. Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data. Acta Otorhinolaryngol Ital. 36(4):249–258.
   PubMed Web of Science ®Google Scholar
• Nawaz A, Mäkinen A, Pärnänen P, Meurman JH. 2018. Proteolytic activity of non-albicans Candida and Candida albicans in oral cancer patients. New Microbiol. 41(4):296–301.
   PubMed Web of Science ®Google Scholar
• Negri M, Gentile A, Angelis C. d, Montò T, Patalano R, Colao A, Pivonello R, Pivonello C. 2020. Vitamin D-induced molecular mechanisms to potentiate cancer therapy and to reverse drug-resistance in cancer cells. Nutrients. 12(6):1798.
   PubMed Web of Science ®Google Scholar
• Nouari W, Ysmail-Dahlouk L, Aribi M. 2016. Vitamin D3 enhances bactericidal activity of macrophage against Pseudomonas aeruginosa. Int Immunopharmacol. 30:94–101.
   PubMed Web of Science ®Google Scholar
• Okoye CC, Bucher J, Tatsuoka C, Parikh SA, Oliveira GH, Gibson MK, Machtay M, Yao M, Zender CA, Dorth JA. 2017. Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy. Head Neck. 39(3):527–532.
   PubMed Web of Science ®Google Scholar
• Olsen I, Yilmaz Ö. 2019. Possible role of Porphyromonas gingivalis in orodigestive cancers. J Oral Microbiol. 11(1):1563410.
   PubMed Web of Science ®Google Scholar
• Orlandi E, Iacovelli NA, Tombolini V, Rancati T, Polimeni A, Cecco LD, Valdagni R, Felice FD. 2019. Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer. Oral Oncol. 99:104453.
   PubMed Web of Science ®Google Scholar
• Özgü E, Yılmaz N, Başer E, Güngör T, Erkaya S, Yakut Hİ. 2016. Could 25-OH vitamin D deficiency be a reason for HPV infection persistence in cervical premalignant lesions? J Exp Ther Oncol. 11(3):177–180.
   PubMed Web of Science ®Google Scholar
• Pai SI, Westra WH. 2009. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 4(1):49–70.
   PubMedGoogle Scholar
• Park DG, Woo BH, Lee BJ, Yoon S, Cho Y, Kim YD, Park HR, Song JM. 2019. Serum levels of interleukin-6 and titers of antibodies against Porphyromonas gingivalis could be potential biomarkers for the diagnosis of oral squamous cell carcinoma. IJMS. 20(11):2749.
   Google Scholar
• PDQ Screening and Prevention Editorial Board. 2002. Oral cavity, pharyngeal, and laryngeal cancer prevention (PDQ®): Health Professional Version. Bethesda (MD): National Cancer Institute (US). http://www.ncbi.nlm.nih.gov/pubmed/26389416.
   Google Scholar
• Perera M, Al-Hebshi NN, Speicher DJ, Perera I, Johnson NW. 2016. Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria. J Oral Microbiol. 8(1):32762.
   PubMed Web of Science ®Google Scholar
• Perillo F, Amoroso C, Strati F, Giuffrè MR, Díaz-Basabe A, Lattanzi G, Facciotti F. 2020. Gut microbiota manipulation as a tool for colorectal cancer management: recent advances in its use for therapeutic purposes. Int J Mol Sci. 21(15):5389.
   PubMed Web of Science ®Google Scholar
• Perri F, Ionna F, Longo F, Scarpati Della VG, De AC, Ottaiano A, Botti G, Caponigro F. 2020. Immune response against head and neck cancer: biological mechanisms and implication on therapy. Transl Oncol. 13(2):262–274.
   PubMed Web of Science ®Google Scholar
• Pevsner-Fischer M, Tuganbaev T, Meijer M, Zhang SH, Zeng ZR, Chen MH, Elinav E. 2016. Role of the microbiome in non-gastrointestinal cancers. World J Clin Oncol. 7(2):200–213.
   PubMed Web of Science ®Google Scholar
• Pittarella P, Squarzanti DF, Molinari C, Invernizzi M, Uberti F, Renò F. 2015. NO-dependent proliferation and migration induced by Vitamin D in HUVEC. J Steroid Biochem Mol Biol. 149:35–42.
   PubMed Web of Science ®Google Scholar
• Plzák J, Bouček J, Bandúrová V, Kolář M, Hradilová M, Szabo P, Lacina L, Chovanec M, Smetana K. 2019. The head and neck squamous cell carcinoma microenvironment as a potential target for cancer therapy. Cancers (Basel). 11(4):440.
   Web of Science ®Google Scholar
• Poropatich K, Hernandez D, Fontanarosa J, Brown K, Woloschak G, Paintal A, Raparia K, Samant S. 2017. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma. J Oral Pathol Med. 46(10):972–978.
   PubMed Web of Science ®Google Scholar
• Prabhu SR, Wilson DF. 2016. Evidence of Epstein-Barr virus association with head and neck cancers: a review. J Can Dent Assoc. 82:g2.
   PubMedGoogle Scholar
• Prodam F, Zanetta S, Ricotti R, Marolda A, Giglione E, Monzani A, Walker GE, Rampone S, Castagno M, Bellone S, et al. 2016. Influence of ultraviolet radiation on the association between 25-hydroxy vitamin D levels and cardiovascular risk factors in obesity. J Pediatr. 171:83–89.e1.
   PubMed Web of Science ®Google Scholar
• Rao SK, Pavicevic Z, Du Z, Kim JG, Fan M, Jiao Y, Rosebush M, Samant S, Gu W, Pfeffer LM, et al. 2010. Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma. J Biol Chem. 285(42):32512–32521.
   PubMed Web of Science ®Google Scholar
• Robayo DAG, Erira HAT, Jaimes FOG, Torres AM, Galindo AIC. 2019. Oropharyngeal squamous cell carcinoma: human papilloma virus coinfection with Streptococcus anginosus. Braz Dent J. 30(6):626–633.
   PubMedGoogle Scholar
• Robles-Vera I, Callejo M, Ramos R, Duarte J, Perez-Vizcaino F. 2019. Impact of vitamin D deficit on the rat gut microbiome. Nutrients. 11(11):2564.
   Web of Science ®Google Scholar
• Rodríguez-Rabassa M, López P, Rodríguez-Santiago R, Cases A, Felici M, Sánchez R, Yamamura Y, Rivera-Amill V. 2018. Cigarette smoking modulation of saliva microbial composition and cytokine levels. IJERPH. 15(11):2479.
   Google Scholar
• Rosa GL, Gattuso G, Pedullà E, Rapisarda E, Nicolosi D, Salmeri M. 2020. Association of oral dysbiosis with oral cancer development (Review). Oncol Lett. 19(4):3045–3058.
   PubMed Web of Science ®Google Scholar
• Sahingur SE, Yeudall WA. 2015. Chemokine function in periodontal disease and oral cavity cancer. Front Immunol. 6:214.
   PubMed Web of Science ®Google Scholar
• Saito K, Pignon P, Ayyoub M, Valmori D. 2015. Modulation of cytokine secretion allows CD4 T cells secreting IL-10 and IL-17 to simultaneously participate in maintaining tolerance and immunity. PLoS One. 10(12):e0145788.
   PubMed Web of Science ®Google Scholar
• Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz ELS, Nightingale K, Kerr AR, DeLacure MD, Veeramachaneni R, Muy-Teck Teh, et al. 2014. Changes in abundance of oral microbiota associated with oral cancer. PLoS One. 9(6):e98741.
   PubMed Web of Science ®Google Scholar
• Schwab M, Reynders V, Loitsch S, Steinhilber D, Stein J, Schröder O. 2007. Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling. Mol Immunol. 44(15):3625–3632.
   PubMed Web of Science ®Google Scholar
• Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. 1998. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev. 7(5):391–395.
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Man Lei Y, Jabri B, Alegre ML, et al. 2015. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 350(6264):1084–1089.
   PubMed Web of Science ®Google Scholar
• Somma CD, Scarano E, Barrea L, Zhukouskaya VV, Savastano S, Mele C, Scacchi M, Aimaretti G, Colao A, Marzullo P. 2017. Vitamin D and neurological diseases: an endocrine view. Int J Mol. Sci. 18(11):2482.
   Web of Science ®Google Scholar
• Squarzanti DF, Sorrentino R, Azzimonti B. 2019. High-risk HPVs, microbiota and epithelial carcinogenesis: state of the art and research contribution of in vitro 3D models. J Cancer Metastasis Treat. 5:73.
   Google Scholar
• Squarzanti DF, Zavattaro E, Pizzimenti S, Amoruso A, Savoia P, Azzimonti B. 2020. Non-Melanoma Skin Cancer: news from microbiota research. Crit Rev Microbiol. 46(4):433–449.
   PubMed Web of Science ®Google Scholar
• Sun J. 2010. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 26(6):591–595.
   PubMed Web of Science ®Google Scholar
• Sundaram K, Sambandam Y, Tsuruga E, Wagner CL, Reddy SV. 2014. 1α,25-Dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells. Horm Cancer. 5(2):90–97.
   PubMed Web of Science ®Google Scholar
• Sustova H, Feudis MD, Reano S, Alves Teixeira M, Valle I, Zaggia I, Agosti E, Prodam F, Filigheddu N. 2019. Opposing effects of 25-hydroxy- and 1α,25-dihydroxy-vitamin D3 on pro-cachectic cytokine-and cancer conditioned medium-induced atrophy in C2C12 myotubes . Acta Physiol (Oxf)). 226(3):e13269.
   PubMed Web of Science ®Google Scholar
• Sztukowska MN, Ojo A, Ahmed S, Carenbauer AL, Wang Q, Shumway B, Jenkinson HF, Wang H, Darling DS, Lamont RJ. 2016. Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells. Cell Microbiol. 18(6):844–858.
   PubMed Web of Science ®Google Scholar
• Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R. 2017. Human papillomavirus-related oropharyngeal cancer. Ann Oncol. 28(10):2386–2398.
   PubMed Web of Science ®Google Scholar
• Tumban E. 2019. A current update on human papillomavirus-associated head and neck cancers. Viruses. 11(10):922.
   PubMed Web of Science ®Google Scholar
• Uberti F, Lattuada D, Morsanuto V, Nava U, Bolis G, Vacca G, Squarzanti DF, Cisari C, Molinari C. 2014. Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. J Clin Endocrinol Metab. 99(4):1367–1374.
   PubMed Web of Science ®Google Scholar
• Vigneswaran N, Williams MD. 2014. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 26(2):123–141.
   PubMed Web of Science ®Google Scholar
• Walker DD, Reeves TD, Costa AM. d, Schuyler C, Young MRI. 2012. Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck. Cytokine. 58(3):448–454.
   PubMed Web of Science ®Google Scholar
• Wang B, Yao M, Lv L, Ling Z, Li L. 2017. The human microbiota in health and disease. Engineering. 3(1):71–82.
   Web of Science ®Google Scholar
• Wang H, Funchain P, Bebek G, Altemus J, Zhang H, Niazi F, Peterson C, Lee WT, Burkey BB, Eng C. 2017. Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas. Genome Med. 9(1):14.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang C, Wang J, Huang X, Cheng Y. 2016. Longitudinal, observational study on associations between postoperative nutritional vitamin D supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci Rep. 6(1):38962.
   PubMedGoogle Scholar
• Wolf A, Moissl-Eichinger C, Perras A, Koskinen K, Tomazic PV, Thurnher D. 2017. The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study. Sci Rep. 7(1):5867.
   PubMedGoogle Scholar
• Woo BH, Kim DJ, Choi JI, Kim SJ, Park BS, Song JM, Lee JH, Park HR. 2017. Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential. Oncotarget. 8(29):46981–46992.
   PubMedGoogle Scholar
• Wu JS, Zheng M, Zhang M, Pang X, Li L, Wang S. s, Yang X, Wu J. b, Tang YJ, Tang Y. l, et al. 2018. Porphyromonas gingivalis promotes 4-nitroquinoline-1-oxide-induced oral carcinogenesis with an alteration of fatty acid metabolism. Front Microbiol. 9:2081.
   PubMed Web of Science ®Google Scholar
• Wu S, Yoon S, Zhang YG, Lu R, Xia Y, Wan J, Petrof EO, Claud EC, Chen D, Sun J. 2015. Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol Gastrointest Liver Physiol. 309(5):G341–G349.
   PubMed Web of Science ®Google Scholar
• Xu CZ, Shi RJ, Chen D, Sun YY, Wu QW, Wang T, Wang PH. 2013. Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell. Int J Clin Exp Pathol. 6(12):2745–2756.
   PubMed Web of Science ®Google Scholar
• Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, Sawayama H, Kinoshita K, Ishimoto T, Iwatsuki M, et al. 2016. Human microbiome fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res. 22(22):5574–5581.
   PubMed Web of Science ®Google Scholar
• Yang CY, Yeh YM, Yu HY, Chin CY, Hsu CW, Liu H, Huang PJ, Hu SN, Liao CT, Chang KP, et al. 2018. Oral microbiota community dynamics associated with oral squamous cell carcinoma staging. Front Microbiol. 9:862.
   PubMed Web of Science ®Google Scholar
• Yokosawa EB, Arthur AE, Rentschler KM, Wolf GT, Rozek LS, Mondul AM. 2018. Vitamin D intake and survival and recurrence in head and neck cancer patients. Laryngoscope. 128(11):E371–E376.
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Takeuchi K, Shibata Y, Kageyama S, Matsumi R, Takeshita T, Yamashita Y. 2018. Characterization of oral microbiota and acetaldehyde production. J Oral Microbiol. 10(1):1492316.
   PubMed Web of Science ®Google Scholar
• Yost S, Stashenko P, Choi Y, Kukuruzinska M, Genco CA, Salama A, Weinberg EO, Kramer CD, Frias-Lopez J. 2018. Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses. Int J Oral Sci. 10(4):32.
   PubMedGoogle Scholar
• Zeljic K, Supic G, Stamenkovic Radak M, Jovic N, Kozomara R, Magic Z. 2012. Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med. 41(10):779–787.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu Y, Zheng HJ, Zhang CP. 2019. The oral microbiota may have influence on oral cancer. Front Cell Infect Microbiol. 9:476.
   PubMed Web of Science ®Google Scholar
• Zhang YG, Wu S, Sun J. 2013. Vitamin D, vitamin D receptor and tissue barriers. Tissue Barriers. 1(1):e23118.
   PubMedGoogle Scholar
• Zheng Y, Trivedi T, Lin RC, Fong-Yee C, Nolte R, Manibo J, Chen Y, Hossain M, Horas K, Dunstan C, et al. 2017. Loss of the vitamin D receptor in human breast and prostate cancers strongly induces cell apoptosis through downregulation of Wnt/β-catenin signaling. Bone Res. 5(1):17023.
   PubMedGoogle Scholar